Cycle 2 goes deeper. Where Cycle 1 introduced each pillar at the level of "what is happening and why does it matter," Cycle 2 explains the mechanisms — the actual biology underneath the symptoms. For the Brain & Hormones pillar, that means one question above all others: what does estrogen actually do in the brain, step by step, that makes its decline so consequential?
The short answer is that estrogen is not a reproductive hormone that happens to affect the brain. It is a brain hormone that happens to govern reproduction. That reframing changes everything about how you understand perimenopause — and what you do about it.
In 1992, scientists made a discovery that fundamentally changed how we understand the female brain: sex hormones — estrogen in particular — influence not only sexual behaviour but brain function itself. The hormones previously classified as "reproductive" turned out to be equally critical for cognition, mood, memory, and neurological health. In other words, the brain and the ovaries are not separate systems. They are one continuous feedback loop.
The X chromosome — which women carry double — contains 1,098 genes compared with the Y chromosome's 78. Many of those additional genes are critical for both hormonal production and brain activity. The female brain is not simply a human brain with different hormones. It is a differently built brain, wired to run on a hormonal fuel that eventually runs out.
The HPG axis and estrogen's five roles in the brain
The HPG axis — how the brain commands the ovaries, and why the feedback matters
The hypothalamic-pituitary-gonadal axis — the HPG axis — is the command chain that governs sex hormone production. The hypothalamus, deep inside the brain, releases gonadotropin-releasing hormone (GnRH), which signals the pituitary gland to release follicle-stimulating hormone (FSH) and luteinising hormone (LH), which in turn instruct the ovaries to produce estrogen and progesterone.
What makes this remarkable is the direction of the feedback: the brain commands the ovaries, and the ovaries report back to the brain in real time, day after day, throughout a woman's life. The hypothalamus is simultaneously the controller and the receiver. It is in continuous contact with the hippocampus (memory), the amygdala (emotion), the posterior cingulate cortex (autobiographical memory), and the frontal cortex (attention, language, reasoning). When estrogen levels drop, the entire network is affected — not just reproductive function.
This is why perimenopause is a neurological event. The ovaries are failing to answer the brain's call, and the brain — which has been calibrated to run on the answer — has to find new ways to function without it.
Estrogen's five roles in the brain
The neurotransmitter cascade — four systems, one hormone
When you understand that estrogen regulates four major neurotransmitter systems simultaneously, the breadth of perimenopausal symptoms stops being surprising. Brain fog, low mood, anxiety, memory lapses, disrupted sleep, and lost motivation are not separate problems. They are the same problem — estrogen withdrawal — expressed across four different neurochemical systems.
"Estrogen is a 'master regulator' in the female brain, serving many roles that actually have nothing to do with reproduction, but rather everything to do with energy."
— Dr. Lisa Mosconi, The XX BrainThe progesterone seesaw — and what happens when it hits the ground
Estrogen doesn't act alone. Progesterone is its counterbalance — the two hormones sit on either end of a seesaw, shifting rhythmically across the menstrual cycle. After age 35, progesterone starts varying unpredictably from month to month. When progesterone drops sharply, estrogen rises on the seesaw without a counterbalancing force — producing the oestrogen dominance symptoms (bloating, migraines, irritability, insomnia) that many women experience in perimenopause, even before estrogen itself begins to fall.
Eventually, both sides of the seesaw collapse. The symptoms that follow — the full spectrum of brain fog, mood instability, sleep disruption, and anxiety — are the consequence of losing not one hormone, but an entire hormonal dialogue that the brain has been conducting since puberty.
The timing hypothesis — why the window matters
Not all interventions work at all times. The "critical window" or "timing hypothesis" describes the window during which hormone therapy can protect the brain: early in the perimenopause transition, when estrogen receptors in the brain are still intact and responsive. MHT initiated in this window is associated with preserved cognitive function, lower Alzheimer's risk, and maintained cerebral metabolism. MHT initiated ten or more years after the final period — when receptor sensitivity has diminished — shows significantly reduced benefit and, in some studies, potential harm.
This is why the conversation about hormone therapy belongs in your forties — not your sixties. The window is open now. It will not stay open indefinitely.
Dr. Sara Gottfried brings a critical reframe to the hot flash conversation on the Huberman Lab podcast: hot flashes and night sweats are not peripheral vascular events — they are brain events. The hypothalamus, which controls thermoregulation, loses its estrogen calibration as perimenopause progresses. The result is a thermostat that fires incorrectly — triggering vasodilation and sweating in response to temperature signals that a well-estrogenised hypothalamus would have managed without incident.
Her broader point: virtually every symptom of perimenopause that appears "physical" — temperature instability, joint pain, skin changes, vaginal changes — is primarily driven by the brain losing its hormonal calibration, not by the body parts themselves malfunctioning. This is a fundamentally different framework, and it shifts the treatment logic. You are not treating a collection of separate symptoms. You are treating a brain that has lost its primary regulatory hormone.
On the microbiome connection: Dr. Gottfried also notes that the estrobolome — the community of gut bacteria that metabolises and recycles estrogen — becomes less efficient as the gut microbiome is disrupted by poor diet, stress, and ageing. Even women with adequate circulating estrogen can experience relative estrogen deficiency if their estrobolome is impaired. The gut-brain-hormone axis is bidirectional and clinically significant.
The four neurotransmitter systems governed by estrogen all leave measurable traces in wearable data. HRV is the most direct proxy — it reflects the balance between sympathetic (cortisol-driven) and parasympathetic (GABA-driven) nervous system tone. A sustained HRV decline correlates with the cortisol dysregulation described above; a rising HRV trend as you implement the lifestyle protocols from this newsletter is a reliable signal that the interventions are working at a neurological level.
For tracking dopamine-related changes specifically: note your motivation and focus quality each morning on a simple 1–5 scale alongside your wearable readiness score. Done over 30 days, this self-report data alongside HRV gives you a richer picture of how your neurochemistry is shifting than either metric alone.
With four neurotransmitter systems depressed by declining estrogen, dietary support becomes a direct clinical tool. Three food categories address three of the four systems covered above.
For serotonin: tryptophan-rich foods — turkey, eggs, oats, pumpkin seeds, tofu — provide the amino acid precursor to serotonin. Pairing tryptophan sources with a small amount of complex carbohydrate at the same meal facilitates absorption into the brain.
For dopamine: tyrosine-rich foods — lean meat, fish, eggs, dairy, beans, almonds — provide the precursor to both dopamine and norepinephrine. B6 and B12 (from Issue 05) are cofactors in this synthesis pathway — which is one more reason the supplement stack matters.
For GABA and cortisol: magnesium — found in dark leafy greens, pumpkin seeds, dark chocolate, legumes — supports GABA receptor function and blunts cortisol reactivity. Most women are deficient. Foods first; supplement if dietary intake is consistently low.
Regular aerobic and resistance exercise compensates for declining estrogen in several of the five brain roles covered above. Exercise independently increases BDNF (brain-derived neurotrophic factor), which promotes the same neuroplasticity that estrogen supports. It also increases cerebral blood flow, provides a direct antidepressant effect via serotonin and endorphin release, and reduces neuroinflammation — effectively substituting for roles 2, 3, 4, and 5 in the list above.
It cannot substitute for role 1 (energy regulation) — the cerebral glucose metabolism effect requires estrogen specifically. But four out of five is a compelling argument. Exercise is the lifestyle intervention with the broadest overlap with what estrogen was doing. That is not a coincidence.
This week: during one of your two resistance sessions, add five minutes of moderate aerobic activity immediately before the strength work — a brisk walk, light cycling, or a short jog. The combination of elevated heart rate followed by resistance load produces the most robust BDNF response of any training format studied.